Heparin-induced thrombocytopenia (HIT) is an immune response to heparin that can
progress to severe thrombosis, amputation, and in some cases death. The diagnosis and …

Background The diagnosis of heparin-induced thrombocytopenia (HIT) is problematic in the
surgical ICU, as there are multiple potential explanations for thrombocytopenia. We …

Routine laboratory measurement of peripheral platelets was introduced only in the 1970s,
and as such, the first published report of HIT complicated by thrombosis dates back to 1969 …

BACKGROUND: Unfractionated and low–molecular-weight heparin are commonly used in
the prevention and therapy of a variety of cardiovascular diseases. Because the major side …

Heparin-induced thrombocytopenia (HIT) is a serious, yet treatable prothrombotic disease
that develops in approximately 0.5% to 5% of heparin-treated patients and dramatically …

Heparin-induced thrombocytopenia (HIT) is an immune-mediated adverse effect that
typically manifests several days after the start of heparin therapy, although both rapid-and …

Heparin is the first glycosaminoglycan ever identified. All the heparin-like
glycosaminoglycans that are also isolated from animal tissues or any polysaccharides that …

Background Vaccine-induced immune thrombocytopenia and thrombosis (VITT) is triggered
by nCOV-19 adenovirus-vectored vaccines against SARS-CoV2. Pathogenesis has been …

For patients with HIT, alternative anticoagulation is available, but for cardiovascular surgery,
if the operation cannot be delayed until HIT antibodies have become negative, alternative …

Danaparoid case reports of 91 pregnancies in 83 patients with a history of thrombophilia
and/or intra-uterine growth retardation have been analysed. All had intolerance to the …